Programme
| Monday September 2nd | ||
| 08:30 | Registration at University of Chemistry and Technology Prague (UCT) | |
| 10:00 | Official Opening – Zdeněk Hostomský, Director IOCB Prague – Karel Melzoch, Rector UCT Prague – His Excellency Daniel Meron, Ambassador of Israel to the Czech Republic – Silvana Jirotková, Deputy Minister of Industry and Trade of Czech Republic |
|
| 10:20 | Martin Fusek (IOCB) Introduction to overall process |
|
| 10:40 | Zdeněk Hostomský (IOCB) Inhibiting PARP - from an idea to registration |
|
| 11:20 | Haim Barr (Weizmann Institute of Science) High-throughput screening and Chemical Probes |
|
| 12:00 | Lunch | |
| 13:30 | Zvi Livneh (Weizmann Institute of Science) Harnessing DNA repair in the fight against lung cancer |
|
| 14:10 | Eric Lansdon (Gilead) Structure-Based Drug Design: Finding Selective Kinase Inhibitors |
|
| 14:50 | Coffee Break | |
| 15:15 | Alexander Domling (University of Groningen) Multicomponent reaction chemistry in drug discovery: from scaffold diversity to automated miniaturized synthesis |
|
| 19:00 | Welcome Party | |
| Tuesday September 3th | ||
| 9:00 | Mads Tang Christensen (Novo Nordisk) From bench to bedside: how a great idea is turned into to a great drug |
|
| 9:40 | Rob Harris (Catalent) Improving chance of success in early drug development |
|
| 10:20 | Coffee Break | |
| 10:45 | Pavlína Řezáčová (IOCB) Protein crystallography in drug design |
|
| 11:25 | František Štěpánek (UCT Prague) Remotely controlled micro devices for enzyme-prodrug therapy |
|
| 12:05 | Lunch | |
| 14:00 | Pavel Majer (IOCB) Prodrugs - Concept and Applications in Discovery and Development of Therapeutics |
|
| 14:40 | Claney Pereira (Vaxxilon) Semi-synthetic Glycoconjugate Vaccines |
|
| 15:20 | Yossi Yarden (Weizmann Institute of Science) Resistance to kinase inhibitors and potential roles for antibodies in lung cancer treatment |
|
| 16:00 | IOCB Tour | |
| Wednesday September 4th | ||
| 9:00 | Lenka Maletínská (IOCB) New therapeutic potential of anorexigenic neuropeptides in experimental Type 3 diabetes: relevance of obesity and neurodegeneration crosstalk |
|
| 9:40 | Michaela Rumlová (UCT Prague) Past, presence and future of HIV-1 |
|
| 10:20 | Coffee Break | |
| 11:00 | Stephan Bachman (Roche) Catalysis as Key Technology in the Synthesis & Scale-up of APIs and Their Intermediates |
|
| 11:40 | Ari-Lev Gruzman (Bar Ilan University) Peptidomimetics for ischemic cardioprotection |
|
| 12:20 | Lunch | |
| 14:30 | Prague City Tour (walking) | |
| 19:00 | Boat trip with dinner | |
| Thursday September 5th | ||
| 9:00 | James Engel (University of Michigan) Developing therapeutics to treat the first molecular disease |
|
| 9:40 | Ladislav Vyklický (Biocev) Glutamate Receptors in Health and Disease |
|
| 10:20 | Coffee Break | |
| 10:50 | Timor Baasov (Technion – Israel Institute of Technology) To Fix Nature's Mistake: Repairing Human Faulty Genes by Small Molecules |
|
| 11:30 | Marc Slack (Evotec) Phenotypic and genetic screening in the context of drug discovery |
|
| 12:10 | Lunch | |
| 13:30 | Daniela Angst (Novartis) Discovery of the irreversible BTK inhibitor LOU064 |
|
| 14:15 | Sergey Zozulya (Enamine) Outsourcing Drug Discovery |
|
| 14:55 | Nir London (Weizmann Institute of Science) Covalent Drug Discovery |
|
| 15:35 | Coffee Break | |
| 16:00 | UCT Tour and Visit of the University Brewery | |
| Friday September 6th | ||
| 9:00 | Igor Komarov (University of Kyiv) Peptide therapeutics: current status and future prospects |
|
| 9:40 | Pavel Hobza (IOCB) In Silico Drug Design - Quantum Mechanical Approach |
|
| 10:20 | Coffee Break | |
| 10:50 | Keith Wreggett (Innospective) Building a commercial opportunity for drug discovery projects in academia |
|
| 11:30 | Zlatko Janeba (IOCB) Prodrugs of nucleotide analogues and their use in medicinal chemistry |
|
| 12:10 | Frank von Delft (University of Oxford) XChem fragment screening and streamlined follow-up |
|
| 12:50 | Closing, best poster award winner | |